Functions of natural killer cells
The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Abstract
Natural killer (NK) cells are effector lymphocytes of the innate immune system that control several types of tumors and microbial infections by limiting their spread and subsequent tissue damage. Recent research highlights the fact that NK cells are also regulatory cells engaged in reciprocal interactions with dendritic cells, macrophages, T cells and endothelial cells. NK cells can thus limit or exacerbate immune responses. Although NK cells might appear to be redundant in several conditions of immune challenge in humans, NK cell manipulation seems to hold promise in efforts to improve hematopoietic and solid organ transplantation, promote antitumor immunotherapy and control inflammatory and autoimmune disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, myofibroblasts that fail to enter senescence and continue to produce scar tissue are resistant to NK activity and perpetuate fibrosis even after the inflammatory stimulus has reduced.84,85”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [84]
Citations
Cites
The biology of human natural killer-cell subsets
Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975 · cited 1×
“In humans, NK cells can be divided into CD56 dim and CD56 bright NK cell subsets, which differ in their homing propertie”
BackgroundBiology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902 · cited 1×
“NK cells were later recognized as a separate lymphocyte lineage, with both cytotoxicity and cytokine-producing effector function”
BackgroundLanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769 · cited 1×
“Activating NK cell receptors detect the presence of ligands on cells in 'distress', such as the stress-induced self ligands recognized by NKG2D (human ULBP and MIC molecules, as well as mouse RAE1, H60 and MULT1 molecules”
BackgroundSelective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161 · cited 1×
“As a consequence, NK cells have been described as able to recognize 'missing self' on hematopoietic cell”
BackgroundNATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113 · cited 1×
“, whereas chemokines such as CCL3 (MIP-1α), CXCL10 (IP-10) and CXCL9 (MIG) coordinately regulate NK cell traffickin”
BackgroundMiller, J. S., Soignier, Y., Panoskaltsis-Mortari, A., McNearney, S. A., Yun, G. H., Fautsch, S. K., McKenna, D., Le, C., Defor, T. E., Burns, L. J., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2974 · Cited by 1,903 · cited 1×
“, and NK cell–mediated therapy after hematopoietic cell transplantation seems saf”
BackgroundDecidual NK cells regulate key developmental processes at the human fetal-maternal interface
Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Cohen-Daniel, L., Arnon, T. I., Manaster, I., et al. (2006) · Nature Medicine · doi:10.1038/nm1452 · Cited by 1,681 · cited 1×
“uNK represent a very distinct subset of NK cells that secrete proangiogenic factors such as vascular endothelial growth factor (VEGF), placental growth factor (PLGF) and NKG5 (ref”
BackgroundInduced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
Martín-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,353
Licensing of natural killer cells by host major histocompatibility complex class I molecules
Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y.-J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., et al. (2005) · Nature · doi:10.1038/nature03847 · Cited by 1,340 · cited 1×
“This education process requires the recognition of self–MHC class I molecules by cognate inhibitory receptors, such as Ly49 molecules in mice and KIRs in human”
BackgroundDirect Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors
Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B., & Lanier, L. L. (2002) · Science · doi:10.1126/science.1070884 · Cited by 1,230
Research works printed but not linked: 1
- Stewart, C.A. & Vivier, E. Strategies of NK cell recognition and their roles in tumor immunosurveillance. in How the Immune System Recognizes Self and Nonself: Immunoreceptors and Their Signaling (ed. Kitamura, D.) 37–81 (Springer, Tokyo, 2007).
Cited by
Items 401–500 of 1,008
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease
Arron, H. E., Marsh, B. D., Khan, M. A., Jaeger, B., Kell, D., & Pretorius, E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1386607 · Cited by 141
“NK cells form part of the innate immune system and control various microbial infections by preventing their spread and subsequent tissue damage (475).”
BackgroundImmune and hemorheological changes in Chronic Fatigue Syndrome
Brenu, E., Staines, D., Baskurt, O. K., Ashton, K. J., Ramos, S. B., Christy, R., & Marshall‐Gradisnik, S. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-1 · Cited by 119
“High levels of TFG-b also cause an increase in neutrophil apoptosis and this occurs in some cases of CFS [11].”
BackgroundInteractions between Human NK Cells and Macrophages in Response to Salmonella Infection
Lapaque, N., Walzer, T., Méresse, S., Vivier, E., & Trowsdale, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803329 · Cited by 109
“NK cells are important immune effectors for preventing microbial invasion and dissemination (1, 2).”
BackgroundSelf-citationNijhof, I. S., van Bueren, J. J. L., van Kessel, B., Andre, P., Morel, Y., Lokhorst, H. M., van de Donk, N. W. C. J., Parren, P. W. H. I., & Mutis, T. (2015) · Haematologica · doi:10.3324/haematol.2014.117531 · Cited by 112
“Based on these observations, we hypothesized that the efficacy of DARA-induced, NK cell-mediated ADCC may be further enhanced via modulation of NK-cell regulatory signals transmitted via the inhibitory and activating NK receptors [killer-cell immunoglobulin-like receptors (KIRs)].(10,11) Since the signals transmitted…”
BackgroundLee, A. J., Chen, B., Chew, M. V., Barra, N. G., Shenouda, M. M., Nham, T., van Rooijen, N., Jordana, M., Mossman, K. L., Schreiber, R. D., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160880 · Cited by 115
“NK cells are an important component of the innate immune response, as they are rapidly activated upon viral infection and can directly recognize infected cells and eliminate them (Vivier et al., 2008).”
BackgroundInfluentialWagner, J., Pfannenstiel, V., Waldmann, A., Bergs, J. W. J., Brill, B., Huenecke, S., Klingebiel, T. E., Rödel, F., Buchholz, C. J., Wels, W. S., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00676 · Cited by 110
“Cytokine stimulation and ex vivo expansion modulate the phenotype and function of NK cells (52).”
BackgroundGalland, S., Vuille, J., Martin, P., Letovanec, I., Caignard, A., Fregni, G., & Stamenkovic, I. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.089 · Cited by 109
“2892 Cell Reports 20, 2891–2905, September 19, 2017 by diverse cell types, including MSCs (Moretta et al., 2001; Spaggiari et al., 2008; Vivier et al., 2008).”
BackgroundGunda, V., Gigliotti, B. J., Ndishabandi, D., Ashry, T., McCarthy, M., Zhou, Z., Amin, S., Freeman, G. J., Alessandrini, A., & Parangi, S. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0296-2 · Cited by 118
“2c), or at subsequent weeks (data not shown), confirming the immune profile changes were not due to alterations in MHC expression, which is a potent stimulus for NK/NKT cell-mediated destruction.(32)”
BackgroundThe Role of Innate Leukocytes during Influenza Virus Infection
Lamichhane, P. P., & Samarasinghe, A. E. (2019) · Journal of Immunology Research · doi:10.1155/2019/8028725 · Cited by 128
“Primary effector functions (cytolysis of infected cells and cytokine secretion [170]) of IAV-stimulated NK cells are facilitated through cytotoxic receptors, NKp46, NKp44, and NKp30, of which viral HA binds directly to sialic acids expressed on NKp46 [171–173] (Figure 3).”
BackgroundNK cells: A double edge sword against SARS-CoV-2
Masselli, E., Vaccarezza, M., Carubbi, C., Pozzi, G., Presta, V., Mirandola, P., & Vitale, M. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100737 · Cited by 116
Staphylococcal trafficking and infection—from ‘nose to gut’ and back
Raineri, E. J. M., Altulea, D., & van Dijl, J. M. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuab041 · Cited by 126
Balsamo, M., Vermi, W., Parodi, M., Pietra, G., Manzini, C., Queirolo, P., Lonardi, S., Augugliaro, R., Moretta, A., Facchetti, F., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201142179 · Cited by 110
NK Cells: Immune Cross-Talk and Therapeutic Implications
Malhotra, A., & Shanker, A. (2011) · Immunotherapy · doi:10.2217/imt.11.102 · Cited by 113
A mouse model links asthma susceptibility to prenatal exposure to diesel exhaust
Manners, S., Alam, R., Schwartz, D. A., & Gorska, M. M. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.10.047 · Cited by 110
The Role of the Immune System in Cutaneous Squamous Cell Carcinoma
Bottomley, M. J., Thomson, J., Harwood, C. A., & Leigh, I. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20082009 · Cited by 118
“Multiple localized subsets can be identified using cell surface markers, which recognize and kill tumor cells through killer receptors [50,51].”
BackgroundEngineering the next generation of CAR-NK immunotherapies
Biederstädt, A., & Rezvani, K. (2021) · International Journal of Hematology · doi:10.1007/s12185-021-03209-4 · Cited by 119
“NK cells physiologically have a life span of only 2 weeks [22] which requires any successful CAR-NK engineering approach to overcome this inherent biological boundary, to achieve sustained responses.”
BackgroundShivakumar, P., Sabla, G. E., Whitington, P. F., Chougnet, C. A., & Bezerra, J. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38879 · Cited by 109
Lung natural killer cells in mice: phenotype and response to respiratory infection
Wang, J., Li, F., Zheng, M., Sun, R., Wei, H., & Tian, Z. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03607.x · Cited by 120
Dichotomous roles of TGF-β in human cancer
Huang, J. J., & Blobe, G. C. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160065 · Cited by 121
Wrann, C. D., Laue, T., Hübner, L., Kuhlmann, S., Jacobs, R., Goudeva, L., & Nave, H. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00057.2011 · Cited by 110
IGF-1 promotes the development and cytotoxic activity of human NK cells
Ni, F., Sun, R., Fu, B., Wang, F., Guo, C., Tian, Z., & Wei, H. (2013) · Nature Communications · doi:10.1038/ncomms2484 · Cited by 107
Natural killer cell–mediated inflammation resolution is disabled in severe asthma
Duvall, M. G., Barnig, C., Cernadas, M., Ricklefs, I., Krishnamoorthy, N., Grossman, N. L., Bhakta, N. R., Fahy, J. V., Bleecker, E. R., Castro, M., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aam5446 · Cited by 114
“In healthy individuals, NK cells in secondary lymphoid organs are primarily CD56bright cells that, when activated, produce cytokines, such as IFN-, but are poor mediators of cytotoxicity (6, 17).”
BackgroundZhu, L., Gangadaran, P., Kalimuthu, S., Oh, J. M., Baek, S. H., Jeong, S. Y., Lee, S.-W., Lee, J., & Ahn, B.-C. (2018) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2018.1489824 · Cited by 105
“cytotoxic effectors contained in their lytic granules [10,29].”
BackgroundPrimary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model
Piranlioglu, R., Lee, E., Ouzounova, M., Bollag, R. J., Vinyard, A. H., Arbab, A. S., Marasco, D., Güzel, M., Cowell, J. K., Thangaraju, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09015-1 · Cited by 118
Pathogenesis of NEC: Role of the innate and adaptive immune response
Denning, T. L., Bhatia, A. M., Kane, A. F., Patel, R. M., & Denning, P. W. (2016) · Seminars in Perinatology · doi:10.1053/j.semperi.2016.09.014 · Cited by 125
“The function of natural killer (NK) cells in anti-tumor and antiviral mediated immunity is well established.(220) More recently, accumulating evidence suggests a fundamental”
BackgroundUrlaub, D., Höfer, K., Müller, M.-L., & Watzl, C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601004 · Cited by 103
“N atural killer cells are innate lymphocytes that participate in the first line of defense against transformed or infected cells (1).”
BackgroundThe role of secreted factors in stem cells-mediated immune regulation
Lin, L., & Du, L. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2017.07.010 · Cited by 107
IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells
Choi, Y. H., Lim, E. J., Kim, S. W., Moon, Y. W., Park, K. S., & An, H. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0652-7 · Cited by 121
Placenta-Derived Exosomes as a Modulator in Maternal Immune Tolerance During Pregnancy
Bai, K., Li, X., Zhong, J., Ng, E. H. Y., Yeung, W. S. B., Lee, C., & Chiu, P. C. N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.671093 · Cited by 126
“In general, dNK have low cytotoxicity and are prone to produce more growth factors with immunomodulatory activities (122).”
BackgroundPonzetta, A., Benigni, G., Antonangeli, F., Sciumè, G., Sanseviero, E., Zingoni, A., Ricciardi, M. R., Petrucci, M. T., Santoni, A., & Bernardini, G. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1320 · Cited by 106
“A number of G protein–coupled receptors belonging to the chemokine receptor family on NK cell surface and their corresponding tissue counter ligands regulate NK cell mobilization into blood from storage tissues including bonemarrowand spleen, and their extravasation and infiltration of tumor-bearing tissues to initiat…”
BackgroundFrom tumor cell metabolism to tumor immune escape
Villalba, M., Rathore, M. G., López-Royuela, N., Krzywińska, E., Garaude, J., & Allende-Vega, N. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.04.024 · Cited by 119
“However, a small amount of surface MHC-I must be maintained, because its absence would make tumor cells targets of natural killer (NK) cells (Vivier et al., 2008).”
BackgroundMICA polymorphism: biology and importance in immunity and disease
Choy, M., & Phipps, M. E. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.01.002 · Cited by 118
Gill, S., Olson, J. A., & Negrin, R. S. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.01.019 · Cited by 108
“In addition to their viral or tumor targets, NK cells also may kill activated autologous CD4+ cells [81] and thus provide a link between the innate and adaptive immune responses [82,83], with a possible additional role in protecting the host from excessive immune response to pathogens [23].”
BackgroundInfluentialNatural killer cells in inflammatory heart disease
Ong, S., Rose, N. R., & Čiháková, D. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.11.010 · Cited by 123
“ILCs include the IFNγ-producing T-bet+ Type 1 ILCs, the IL4secreting Th2-associated GATA3+ Type 2, and the IL17A-producing Rorγt+ Type 3 ILCs [11,12].”
InfluentialSehgal, A., Mehta, S., Sahay, K., Martynova, E. V., Rizvanov, A. A., Baranwal, M., Chandy, S., Khaiboullina, S. F., Kabwe, E., & Davidyuk, Y. N. (2023) · Viruses · doi:10.3390/v15020561 · Cited by 122
Diet and cancer prevention: the roles of observation and experimentation
Martínez, M. E., Marshall, J. R., & Giovannucci, E. L. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2441 · Cited by 114
Jing, Y., Huang, L., Lv, W., Tong, H., Song, L., Hu, X., & Yu, R. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf404752c · Cited by 107
Evidence for CD16a-Mediated NK Cell Stimulation in Antibody-Mediated Kidney Transplant Rejection
Parkes, M., Halloran, P. F., & Hidalgo, L. G. (2016) · Transplantation · doi:10.1097/tp.0000000000001586 · Cited by 111
GITR Ligand Provided by Thrombopoietic Cells Inhibits NK Cell Antitumor Activity
Placke, T., Salih, H. R., & Kopp, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103194 · Cited by 107
“A second major effector mechanism by which NK cells contribute to antitumor immunity is their role as an “early source of IFN-g” (17, 18).”
BackgroundSivori, S., Falco, M., Carlomagno, S., Romeo, E., Soldani, C., Bensussan, A., Viola, A., Moretta, L., & Moretta, A. (2010) · Blood · doi:10.1182/blood-2009-12-256586 · Cited by 118
Targeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical Approaches
Carotta, S. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00152 · Cited by 107
“ADCC therapy: binding of mAbs (red) to tumor-specific antigens (TSA) results in the activation of NK cells via the activation of the activating receptor CD16 (red).”
BackgroundInfluentialWaight, J. D., Chand, D., Dietrich, S., Gombos, R., Horn, T., Gonzalez, A. M., Manrique, M., Swiech, L., Morin, B., Brittsan, C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.005 · Cited by 104
Immunotherapy for hepatocellular carcinoma: recent advances and future perspectives
Xu, W., Liu, K., Chen, M., Sun, J., McCaughan, G. W., Lu, X., & Ji, J. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919862692 · Cited by 107
Replicative potential of human natural killer cells
Fujisaki, H., Kakuda, H., Imai, C., Mullighan, C. G., & Campana, D. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07667.x · Cited by 105
“In addition to their direct antitumour activity, NK cells influence immune responses by interacting with dendritic cells, macrophages, T cells and endothelial cells (Vivier et al, 2008).”
BackgroundNatural Killer Cells Limit Cardiac Inflammation and Fibrosis by Halting Eosinophil Infiltration
Ong, S., Ligons, D. L., Barin, J. G., Wu, L., Talor, M. V., Diny, N., Fontes, J. A., Gebremariam, E., Kass, D. A., Rose, N. R., et al. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.11.023 · Cited by 100
Offersen, R., Nissen, S. K., Rasmussen, T. A., Østergaard, L. J., Denton, P. W., Søgaard, O. S., & Tolstrup, M. (2016) · Journal of Virology · doi:10.1128/jvi.00222-16 · Cited by 103
“FUNDING INFORMATION This work, including the efforts of Ole Schmeltz Søgaard, was funded by Danish Research Council (12-133887).”
BackgroundMethodIraolagoitia, X. L. R., Spallanzani, R. G., Torres, N. I., Araya, R. E., Ziblat, A., Domaica, C. I., Sierra, J. M., Núñez, S. Y., Secchiari, F., Gajewski, T. F., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502291 · Cited by 107
Vito, C. D., Mikulak, J., Zaghi, E., Pesce, S., Marcenaro, E., & Mavilio, D. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.03.004 · Cited by 120
Decrease post-transplant relapse using donor-derived expanded NK-cells
Ciurea, S. O., Kongtim, P., Soebbing, D., Trikha, P., Behbehani, G. K., Rondón, G., Olson, A. L., Bashir, Q., Gulbis, A. M., Indreshpal, K., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01349-4 · Cited by 102
Yamanaka, Y. J., Berger, C. T., Sips, M., Cheney, P. C., Alter, G., & Love, J. C. (2012) · Integrative Biology · doi:10.1039/c2ib20167d · Cited by 104
The New Deal: A Potential Role for Secreted Vesicles in Innate Immunity and Tumor Progression
Benito-Martin, A., Di Giannatale, A., Ceder, S., & Peinado, H. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00066 · Cited by 100
“Different factors recruit NK cells to the peripheral tissues, such as IL-12, IL-15, IL-2, IFN-α, or β, and their role in innate immunity and in anti-tumor defense has been studied (88).”
BackgroundTranscription Factor Runx3 Regulates Interleukin-15-Dependent Natural Killer Cell Activation
Levanon, D., Negreanu, V., Lotem, J., Bone, K. R., Brenner, O. J., Leshkowitz, D., & Groner, Y. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01202-13 · Cited by 102
Lusty, E., Poznanski, S. M., Kwofie, K., Mandur, T. S., Lee, D. A., Richards, C. D., & Ashkar, A. A. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.06.025 · Cited by 111
Innate and Adaptive Immunity to Mucorales
Ghuman, H., & Voelz, K. (2017) · Journal of Fungi · doi:10.3390/jof3030048 · Cited by 108
“NK cell activity is highly dependent upon signalling from macrophages, DCs, and T cells [50].”
BackgroundImmune Cell-Derived Extracellular Vesicles – New Strategies in Cancer Immunotherapy
Yang, P., Peng, Y., Yuan, F., Xu, Z., Feng, P., Cao, J., Chen, Y., Chen, X., Cao, X., Yang, Y., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.771551 · Cited by 115
“Under steady-state conditions, NK cell activity is stringently controlled by membrane-expressed inhibitory receptors binding to human leukocyte antigen (HLA) molecules, which block activating receptors of NK cells from binding to specific molecules (49).”
BackgroundChimeric antigen receptor T ( CAR‐T ) cells: Novel cell therapy for hematological malignancies
Abbasi, S., Totmaj, M. A., Abbasi, M., Hajazimian, S., Goleij, P., Behroozi, J., Shademan, B., Isazadeh, A., & Baradaran, B. (2022) · Cancer Medicine · doi:10.1002/cam4.5551 · Cited by 111
NF-κB role on tumor proliferation, migration, invasion and immune escape
Khan, A., Zhang, Y., Ma, N., Shi, J., & Hou, Y. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00811-6 · Cited by 115
“NF-κ B also in fl uences the expression of cytotoxic effector molecules, such as perforin and granzyme B, in NK cells, these cells directly kill tumor cells to exhibit their anti-tumor function [109].”
Bartel, Y., Bauer, B., & Steinle, A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00362 · Cited by 97
Obesity: An Immunometabolic Perspective
Ray, I., Mahata, S. K., & De, R. K. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00157 · Cited by 122
Morandi, F., Yazdanifar, M., Cocco, C., Bertaina, A., & Airoldi, I. (2020) · Cells · doi:10.3390/cells9081757 · Cited by 106
Sertoli Cell Immune Regulation: A Double-Edged Sword
Washburn, R. L., Hibler, T., Kaur, G., & Dufour, J. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.913502 · Cited by 113
Esin, S., Counoupas, C., Aulicino, A., Brancatisano, F. L., Maisetta, G., Bottai, D., Luca, M. D., Florio, W., Campa, M., & Batoni, G. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12052 · Cited by 100
The evolution of natural killer cell receptors
Carrillo-Bustamante, P., Keşmir, C., & de Boer, R. D. (2015) · Immunogenetics · doi:10.1007/s00251-015-0869-7 · Cited by 91
“Natural killer (NK) cells are large granular cells that play a pivotal role in controlling viral infections and tumors (Vivier et al. 2008).”
Wang, S., Zhang, Q., Hui, H., Agrawal, K., Karris, M., & Rana, T. M. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1826361 · Cited by 110
“NK cell cytokine secretion and cytotoxic functions are controlled by multiple activating and inhibitory receptors [50].”
BackgroundSanborn, K. B., Rak, G. D., Maru, S. Y., Demers, K., Difeo, A., Martignetti, J. A., Betts, M. R., Favier, R., Banerjee, P. P., & Orange, J. S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804337 · Cited by 87
“Western blot of density gradient fractions, from least (1) to most dense (7) as well as the postnuclear lysate (PNL) and crude lysosomal fraction (CLF) 6978 MYOSIN IIA AND NK CELL LYTIC GRANULE FUNCTION”
BackgroundEguizabal, C., Zenarruzabeitia, O., Monge, J., Santos, S., Vesga, M. A., Maruri, N., Arrieta, A., Riñón, M., Tamayo-Orbegozo, E., Amo, L., et al. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00439 · Cited by 99
“NK cells spare healthy cells that express MHC class I molecules and low amounts of stress-induced self-molecules, while they kill target cells that up-regulate stress-induced self-molecules and/or down-regulate MHC class I molecules (4, 5, 11, 12).”
BackgroundEbihara, T., Azuma, M., Oshiumi, H., Kasamatsu, J., Iwabuchi, K., Matsumoto, K., Saito, H., Taniguchi, T., Matsumoto, M., & Seya, T. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091573 · Cited by 105
“Approximately 20 receptors contribute to NK activation (Cerwenka and Lanier, 2001; Vivier et al., 2008).”
Hide-and-seek: the interplay between cancer stem cells and the immune system
Sultan, M., Coyle, K. M., Vidovic, D., Thomas, M. L., Gujar, S. A., & Marcato, P. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw115 · Cited by 103
Coffee and autoimmunity: More than a mere hot beverage!
Sharif, Κ., Watad, ., Bragazzi, N. L., Adawi, M., Amital, H., & Shoenfeld, Y. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.05.007 · Cited by 111
Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis
Soo, R. A., Chen, Z., Teng, R. S. Y., Tan, H.-L., Iacopetta, B. J., Tai, B. C., & Soong, R. (2018) · Oncotarget · doi:10.18632/oncotarget.24835 · Cited by 104
“Natural killer (NK) cells are the major effector cells of the innate immune system, and have an important role in the immune response against cancer [33].”
BackgroundBai, F., Thompson, E. A., Vig, P. J. S., & Leis, A. A. (2019) · Pathogens · doi:10.3390/pathogens8040193 · Cited by 114
“NK cells are able to kill virally infected cells by inducing apoptosis of the target cells that are missing major-histocompatibility complex (MHC) class I by releasing cytotoxic granules containing perforin and granzymes as well as producing inflammatory cytokines that limit infection [80].”
Engineering nanoparticles to overcome immunological barriers for enhanced drug delivery
Malachowski, T., & Hassel, A. (2020) · Engineered Regeneration · doi:10.1016/j.engreg.2020.06.001 · Cited by 129
Fang, Q., Stehr, A. M., Naschberger, E., Knopf, J., i, M. H., & Stürzl, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1075260 · Cited by 114
Bahman, F., Choudhry, K., Al‐Rashed, F., Al‐Mulla, F., Sindhu, S. T. A. K., & Ahmad, R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1421346 · Cited by 117
Natural killer cells in atopic and autoimmune diseases of the skin
von Bubnoff, D., Andrès, E., Hentges, F., Bieber, T. R. M., Michel, T., & Zimmer, J. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.11.020 · Cited by 110
Intraperitoneal immune cell status in infertile women with and without endometriosis
Tariverdian, N., Siedentopf, F., Rücke, M., Blois, S. M., Klapp, B. F., Kentenich, H., & Arck, P. (2009) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2008.12.005 · Cited by 112
Nanoparticle-Based Modulation of the Immune System
Fang, R. H., & Zhang, L. (2016) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-080615-034446 · Cited by 109
NK Cells and Cancer Immunoediting
Guillerey, C., & Smyth, M. J. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_446 · Cited by 111
Immune responses in the Parkinson's disease brain
Weiss, F. C., Labrador‐Garrido, A., Dzamko, N. L., & Halliday, G. M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105700 · Cited by 104
Umbilical Cord Mesenchymal Stem Cells Increase Expansion of Cord Blood Natural Killer Cells
Boissel, L., Tuncer, H. H., Betancur, M., Wolfberg, A., & Klingemann, H. (2008) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2008.06.016 · Cited by 97
Host response to Candida albicans bloodstream infection and sepsis
Duggan, S., Leonhardt, I., Hünniger, K., & Kurzai, O. (2015) · Virulence · doi:10.4161/21505594.2014.988096 · Cited by 97
The role of AhR in transcriptional regulation of immune cell development and function
Trikha, P., & Lee, D. A. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.188335 · Cited by 96
Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN) signaling pathway
Rojas, J. M., Alejo, A., Martín, V., & Sevilla, N. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03671-z · Cited by 108
Aruldass, A. R., Kitzbichler, M. G., Morgan, S. E., Lim, S., Lynall, M.-E., Turner, L., Vertes, P., Cavanagh, J., Cowen, P., Pariante, C. M., et al. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.08.226 · Cited by 98
The Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies
Zhang, Z., Huang, Q., Yu, L., Zhu, D., Li, Y., Xue, Z., Hua, Z., Luo, X., Song, Z., Lu, C. C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.807895 · Cited by 109
“1 NK Cells The most distinguishing feature of NK cells is that their ability to kill without first recognizing tumor-specific antigens (41).”
BackgroundCastillo, E. F., Stonier, S. W., Frasca, L., & Schluns, K. S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900719 · Cited by 111
“The highlight of NK cell development is the generation of NK cells that can mount an early immune response regulated by cytokine activation or down-regulation of self MHC class Ia (35).”
BackgroundOn the Way to Become a Natural Killer Cell
Vito, C. D., Mikulak, J., & Mavilio, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01812 · Cited by 108
The Natural Killer–Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy
Peterson, E. E., & Barry, K. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.621254 · Cited by 115
“in (2, 7, 11, 12)], and have a role in cancer prevention (13).”
BackgroundTakeda, K., Nakayama, M., Sakaki, M., Hayakawa, Y., Imawari, M., Ogasawara, K., Okumura, K., & Smyth, M. J. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0411208 · Cited by 96
“This early result was then supported by the finding that NK cell depletion using anti-ASGM1 antibody increased B16 lung metastasis in B6 WT mice [12], although antibody treatment possibly depleted other cell populations [1].”
BackgroundResultHuman Cytokine-Induced Memory-Like Natural Killer Cells
Berrien-Elliott, M. M., Wagner, J. A., & Fehniger, T. A. (2015) · Journal of Innate Immunity · doi:10.1159/000382019 · Cited by 111
The unusual suspects—innate lymphoid cells as novel therapeutic targets in IBD
Goldberg, R., Prescott, N. J., Lord, G. M., MacDonald, T. T., & Powell, N. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.52 · Cited by 106
Cany, J., van der Waart, A. B., Tordoir, M., Franssen, G. M., Hangalapura, B. N., de Vries, I. J. M., Boerman, O. C., Schaap, N. P., van der Voort, R., Spanholtz, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064384 · Cited by 99
“of the innate immune system and play a key role in control against virus infection and tumor immunosurveillance [6,7].”
BackgroundCytokines and Interferons: Types and Functions
Ferreira, V. L., Borba, H. H. L., Bonetti, A. D. F., Leonart, L. P., & Pontarolo, R. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.74550 · Cited by 97
“It is possible to say that NK cells play, in innate immune response, similar functions than cytotoxic T cells in adaptive immune response [23, 24].”
BackgroundNath, P. R., Pal-Nath, D., Mandal, A., Cam, M. C., Schwartz, A. L., & Roberts, D. D. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0367 · Cited by 103
“Cytotoxic NK cells are key effectors in cancer immune surveillance, transplantation rejection, and viral immunity (48).”
BackgroundThioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells
Yang, Y., Neo, S., Chen, Z., Cui, W., Chen, Y., Guo, M., Wang, Y., Xu, H., Kurzay, A., Alici, E., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137585 · Cited by 98
Memory-like natural killer cells for cancer immunotherapy
Gang, M., Wong, P., Berrien-Elliott, M. M., & Fehniger, T. A. (2020) · Seminars in Hematology · doi:10.1053/j.seminhematol.2020.11.003 · Cited by 105
Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment
Yu, S., Wang, Y., He, P., Shao, B., Liu, F., Xiang, Z., Yang, T., Zeng, Y., He, T., Ma, J., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.809304 · Cited by 115
“Thus, tumor cells are vulnerable to NK cellmediated lysis (20).”
BackgroundOvercoming tumor resistance mechanisms in CAR-NK cell therapy
Valeri, A., García-Ortiz, A., Castellano, E., Córdoba, L., Maroto-Martín, E., Encinas, J., Leivas, A., Río, P., & Martínez‐López, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.953849 · Cited by 103
Induction of CD 4+ and CD 8+ anti‐tumor effector T cell responses by bacteria mediated tumor therapy
Stern, C., Kasnitz, N., Kocijancic, D., Trittel, S., Riese, P., Guzmán, C. A., Leschner, S., & Weiß, S. (2015) · International Journal of Cancer · doi:10.1002/ijc.29567 · Cited by 94
“Adoptive T cell transfer into Rag2cc mice NK cells could be the cell population indirectly responsible for the effector function of the CD4(1) T cells resulting in tumor rejection.(28) Therefore, the transfer of tumor-immune Figure 5.”
BackgroundMehrotra, P., Collett, J. A., McKinney, S. D., Stevens, J., Ivancic, C. M., & Basile, D. P. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00462.2016 · Cited by 99
Metadata
- Authors
- Vivier, E., Tomasello, E., Baratin, M., Walzer, T., & Ugolini, S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Venue
- Nature Immunology
- Published
- 2008-04-18
- Volume
- 9
- Issue
- 5
- Pages
- 503-510
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2073300038
- Cited by
- 3,943
- References
- 109
- Citations by year
- 2026: 195 · 2025: 269 · 2024: 299 · 2023: 292 · 2022: 302 · 2021: 332 · 2020: 260 · 2019: 271 · 2018: 224 · 2017: 247 · 2016: 202 · 2015: 195 · 2014: 159 · 2013: 156 · 2012: 141
- FWCI
- 9.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- European Commission
- Agence Nationale de la Recherche
- Institut National de la Santé et de la Recherche Médicale
- Ministère de l'Enseignement Supérieur et de la Recherche
- Centre National de la Recherche Scientifique
- Institut Universitaire de France
- Institut National Du Cancer
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- natural killer cells, innate immunity, tumor control, microbial infection, regulatory function, dendritic cells, macrophages, T cells, endothelial cells, immune regulation, hematopoietic stem cell transplantation, solid organ transplantation, cancer immunotherapy, inflammation, autoimmune disease
- MeSH terms
- Animals, Autoimmune Diseases, Dendritic Cells, Host vs Graft Reaction, Humans, Immune Tolerance, Inflammation, Killer Cells, Natural, Macrophages, Neoplasms, T-Lymphocytes, Virus Diseases, Immunotherapy, Adoptive, Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.